Hand tapping: A simple, reproducible, objective marker of motor dysfunction in Huntington's disease

被引:28
作者
Michell, A. W. [1 ]
Goodman, A. O. G. [2 ,3 ]
Silva, A. H. D. [2 ]
Lazic, S. E. [2 ]
Morton, A. J. [3 ]
Barker, R. A. [2 ,4 ]
机构
[1] UCL Natl Hosp Neurol & Neurosurg, Dept Clin Neurophysiol, London WC1N 3BG, England
[2] Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England
[3] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England
[4] Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England
基金
加拿大自然科学与工程研究理事会; 英国医学研究理事会;
关键词
Huntington disease; biomarker; hand tapping;
D O I
10.1007/s00415-008-0859-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease (HD) is a severe neuro degenerative condition in which the impairment in voluntary movement is related to functional disability. Clinical assessment of motor deficit currently relies largely on subjective rating scales without objective measurement. We have developed a quick and easy-to-use hand tapping device that enables measurement of (a) the number of taps in 30 seconds, (b) variability in tapping rhythm and (c) fatigue over the testing period. Initial cross-sectional testing of 178 consecutive HD clinic patients using an early model of the device showed that the total number of taps in 30 seconds correlated with the motor UHDRS (Spearmann's rho, r(s) = -0.81, p < 0.0001) and independence scores (r(s) = 0.78, p = 0.01). Longitudinal data from a small cohort followed over 10 years reveals a correlation between total number of taps in 30 seconds and motor UHDRS over time (r(s) = -0.49, p < 0.001), and suggests the technique may provide an objective measure of-disease progression. Further tests on 15 HD patients and 9 controls were repeated three times in a single day using an updated device. The HID group made significantly fewer taps in 30 seconds (median HD = 79, control = 104, p = 0.009) and had greater variability of inter-tap interval (mean interdecile range HD = 148, control = 56, p = 0.016) compared to controls. Both the total number of taps and variability of inter-tar) interval correlated with motor UHDRS. Of vital importance for any potential marker of disease progression is that these tapping parameters were reproducible with repeated measurement. Given that hand tapping parameters differ between HD and control populations, they correlate with motor UHDRS over time and are reproducible, we propose that assessment of hand tapping represents a useful objective adjunct to the clinical assessment of HD patients.
引用
收藏
页码:1145 / 1152
页数:8
相关论文
共 21 条
[1]   Assessment of simple movements and progression of Huntington's disease [J].
Andrich, Juergen ;
Saft, Carsten ;
Ostholt, Natalie ;
Mueller, Thomas .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (04) :405-407
[2]   Retest effects and cognitive decline in longitudinal follow-up of patients with early HD [J].
Bachoud-Lévi, AC ;
Maison, P ;
Bartolomeo, P ;
Boissé, MF ;
Dalla Barba, G ;
Ergis, AM ;
Baudic, S ;
Degos, JD ;
Cesaro, P ;
Peschanski, M .
NEUROLOGY, 2001, 56 (08) :1052-1058
[3]   TRINUCLEOTIDE REPEAT LENGTH INSTABILITY AND AGE-OF-ONSET IN HUNTINGTONS-DISEASE [J].
DUYAO, M ;
AMBROSE, C ;
MYERS, R ;
NOVELLETTO, A ;
PERSICHETTI, F ;
FRONTALI, M ;
FOLSTEIN, S ;
ROSS, C ;
FRANZ, M ;
ABBOTT, M ;
GRAY, J ;
CONNEALLY, P ;
YOUNG, A ;
PENNEY, J ;
HOLLINGSWORTH, Z ;
SHOULSON, I ;
LAZZARINI, A ;
FALEK, A ;
KOROSHETZ, W ;
SAX, D ;
BIRD, E ;
VONSATTEL, J ;
BONILLA, E ;
ALVIR, J ;
CONDE, JB ;
CHA, JH ;
DURE, L ;
GOMEZ, F ;
RAMOS, M ;
SANCHEZRAMOS, J ;
SNODGRASS, S ;
DEYOUNG, M ;
WEXLER, N ;
MOSCOWITZ, C ;
PENCHASZADEH, G ;
MACFARLANE, H ;
ANDERSON, M ;
JENKINS, B ;
SRINIDHI, J ;
BARNES, G ;
GUSELLA, J ;
MACDONALD, M .
NATURE GENETICS, 1993, 4 (04) :387-392
[4]  
FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605
[5]   Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches [J].
Hinton, Sean C. ;
Paulsen, Jane S. ;
Hoffmann, Raymond G. ;
Reynolds, Norman C. ;
Zimbelman, Janice L. ;
Rao, Stephen M. .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2007, 13 (03) :539-543
[6]   Unified Huntington's disease rating scale: Reliability and consistency [J].
Kieburtz, K ;
Penney, JB ;
Como, P ;
Ranen, N ;
Shoulson, I ;
Feigin, A ;
Abwender, D ;
Greenamyre, JT ;
Higgins, D ;
Marshall, FJ ;
Goldstein, J ;
Steinberg, K ;
Shih, C ;
Richard, I ;
Hickey, C ;
Zimmerman, C ;
Orme, C ;
Claude, K ;
Oakes, D ;
Sax, DS ;
Kim, A ;
Hersch, S ;
Jones, R ;
Auchus, A ;
Olsen, D ;
BisseyBlack, C ;
Rubin, A ;
Schwartz, R ;
Dubinsky, R ;
Mallonee, W ;
Gray, C ;
Godfrey, N ;
Suter, G ;
Shannon, KM ;
Stebbins, GT ;
Jaglin, JA ;
Marder, K ;
Taylor, S ;
Louis, E ;
Moskowitz, C ;
Thorne, D ;
Zubin, N ;
Wexler, N ;
Swenson, MR ;
Paulsen, J ;
Swerdlow, N ;
Albin, R ;
Wernette, C ;
Walker, F ;
Hunt, V .
MOVEMENT DISORDERS, 1996, 11 (02) :136-142
[7]   Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene [J].
Kirkwood, SC ;
Siemers, E ;
Bond, C ;
Conneally, PM ;
Christian, JC ;
Foroud, T .
ARCHIVES OF NEUROLOGY, 2000, 57 (07) :1040-1044
[8]   CORE ASSESSMENT PROGRAM FOR INTRACEREBRAL TRANSPLANTATIONS (CAPIT) [J].
LANGSTON, JW ;
WIDNER, H ;
GOETZ, CG ;
BROOKS, D ;
FAHN, S ;
FREEMAN, T ;
WATTS, R .
MOVEMENT DISORDERS, 1992, 7 (01) :2-13
[9]   The use of the R6 transgenic mouse models of Huntington' s disease in attempts to develop novel therapeutic strategies [J].
Li J.Y. ;
Popovic N. ;
Brundin P. .
NeuroRX, 2005, 2 (3) :447-464
[10]  
Liao JJZ, 2000, PDA J PHARM SCI TECH, V54, P23